Clinical Trials Directory

Trials / Conditions / Ureter Cancer

Ureter Cancer

30 registered clinical trials studyying Ureter Cancer — 9 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPerformance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients
NCT06469229
Changhai Hospital—
Not Yet RecruitingUrine DNA Methylation Detection for Hematuria Evaluation
NCT06427993
Changhai Hospital—
RecruitingSpinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
NCT06349668
Hans BahlmannPhase 3
RecruitingDevelopment of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Ana
NCT04625556
Yonsei University—
RecruitingRadiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
NCT06652022
Peking University First HospitalN/A
RecruitingPostoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
NCT06598761
Peking University First Hospital—
UnknownUroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
NCT05043662
Changhai Hospital—
CompletedThe Registry of Oncology Outcomes Associated With Testing and Treatment
NCT04028479
Taproot Health—
RecruitingDevelopment of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing
NCT04197414
Yonsei University—
CompletedStudy Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
NCT03520231
University Health Network, TorontoPhase 2
RecruitingAnalysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
NCT03291028
Fox Chase Cancer Center—
TerminatedAfatinib in Advanced Refractory Urothelial Cancer
NCT02122172
University of ChicagoPhase 2
UnknownPemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemother
NCT03193788
Asan Medical CenterPhase 3
UnknownFour Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma
NCT03296306
Asan Medical CenterPhase 3
CompletedCLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
NCT03013920
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)—
CompletedEnzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
NCT02300610
H. Lee Moffitt Cancer Center and Research InstitutePhase 1
CompletedA Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
NCT02665039
Dr Anders UllénPhase 2
RecruitingIntegrated Cancer Repository for Cancer Research
NCT02012699
University of Nebraska—
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
WithdrawnGemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and
NCT01639521
University of Southern CaliforniaPhase 2
CompletedPhase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothe
NCT01844947
Dr Anders UllénPhase 1
CompletedA Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial C
NCT01326871
Altor BioSciencePhase 1 / Phase 2
CompletedTRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
NCT01328574
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignanci
NCT01182168
Memorial Sloan Kettering Cancer CenterPhase 1
CompletedCarboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patient
NCT01191892
Cardiff UniversityPhase 2
Active Not RecruitingA Genotype-Phenotype Urothelial Cancer Registry
NCT00902590
Memorial Sloan Kettering Cancer Center—
CompletedA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
NCT00661609
AstraZenecaPhase 2
CompletedStudy of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platin
NCT01426126
Asan Medical CenterPhase 2
CompletedPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transition
NCT00072150
National Cancer Institute (NCI)Phase 2
CompletedArsenic Trioxide in Treating Patients With Urothelial Cancer
NCT00009867
National Cancer Institute (NCI)Phase 2